Swiss Biotech Windward Raises $225 Million in US IPO, Placement
Bloomberg Markets
12 lis 2026, 23:55Crypto
1 min read
Swiss biotech Windward Bio Group AG raised about $225 million in a US initial public offering that priced at the midpoint of its marketed range, along with a private placement.
The Swiss biotechnology firm successfully completed its US offering, combining an IPO with a private placement to raise substantial capital.
Related
Article written by AI
Z.ai GLM-4.5-FlashFree